Cellebrite CRO sells 12,658 shares in tax-related trade

Cellebrite DI Ltd. Global Chief Revenue Officer Marcus Jewell reported an open-market sale of 12,658 ordinary shares at a weighted average price of $12.7711 per share.

Rhea-AI Filing Summary

Cellebrite DI Ltd. Global Chief Revenue Officer Marcus Jewell reported an open-market sale of 12,658 ordinary shares at a weighted average price of $12.7711 per share. The shares were originally granted as RSUs, and the disposition is associated with tax obligations from their vesting. Following the sale, Jewell directly holds 440,101 ordinary shares.

Insider Trade Summary

Net Seller: 12,658 shares

Net Sell 1 txn

Insider Jewell Marcus

Role Global Chief Revenue Officer

Sold 12,658 shs ($162K)

Type	Security	Shares	Price	Value
Sale	Ordinary shares, par value NIS 0.00001	12,658	$12.7711	$162K

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 440,101 shares (Direct)

Footnotes (2)

1. F1. The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.43 to $12.9807, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 12,658 shares Weighted average sale price: $12.7711 per share Sale price range: $12.43–$12.9807 per share +2 more

5 metrics

Shares sold 12,658 shares Open-market sale on 2026-05-18

Weighted average sale price $12.7711 per share Open-market sale on 2026-05-18

Sale price range $12.43–$12.9807 per share Multiple transactions, same date

Shares held after transaction 440,101 shares Direct ownership following sale

RSU grant date November 15, 2023 RSUs from which sold shares originated

Key Terms

restricted stock units ("RSUs"), weighted average price, open-market sale, Global Chief Revenue Officer

4 terms

restricted stock units ("RSUs") financial

"The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Global Chief Revenue Officer financial

"officer_title: "Global Chief Revenue Officer""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cellebrite (CLBT) report for Marcus Jewell?

Cellebrite reported that Global Chief Revenue Officer Marcus Jewell sold 12,658 ordinary shares. The transaction was an open-market sale tied to tax obligations arising from the vesting of previously granted restricted stock units.

At what price did Marcus Jewell sell Cellebrite (CLBT) shares?

Marcus Jewell sold 12,658 ordinary shares at a weighted average price of $12.7711 per share. Footnotes state the individual trades occurred between $12.43 and $12.9807, with detailed trade data available upon request from the company or regulators.

How many Cellebrite (CLBT) shares does Marcus Jewell hold after this sale?

After the reported sale, Marcus Jewell directly holds 440,101 ordinary shares of Cellebrite. This figure reflects his remaining position following the 12,658-share disposition associated with tax obligations linked to the vesting of restricted stock units.

Why was Marcus Jewell’s Cellebrite (CLBT) share sale linked to RSUs?

The filing explains the sold shares came from RSUs granted on November 15, 2023. The disposition is associated with tax obligations triggered when those restricted stock units vested, making the sale part of handling related tax liabilities rather than a standalone discretionary transaction.

What does the weighted average price mean in the Cellebrite (CLBT) Form 4?

The weighted average price of $12.7711 reflects multiple trades executed between $12.43 and $12.9807. The insider notes that detailed share counts at each specific price within this range can be provided to the issuer, security holders, or SEC staff upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 08:39 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jewell Marcus

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Chief Revenue Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	05/18/2026		S		12,658(1)	D	$12.7711(2)	440,101	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported as disposed herein were granted on November 15, 2023, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.43 to $12.9807, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Marcus Jewell	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)